Valuation: Getinge AB

Market Cap 67.11B 6.68B 5.96B 5.55B 5.05B 9.52B 644B 9.59B 26.11B 328B 25.09B 24.55B 1,056B P/E 2026 *
21.2x
P/E 2027 * 18.9x
Enterprise Value 75.32B 7.5B 6.69B 6.23B 5.67B 10.68B 722B 10.76B 29.31B 369B 28.16B 27.55B 1,185B EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.95x
Free-Float
79.13%
Yield 2026 *
2.1%
Yield 2027 * 2.29%
1 day+0.96%
1 week-2.13%
Current month+0.26%
1 month-0.62%
3 months+16.66%
6 months+21.30%
Current year+4.67%
1 week 24.44
Extreme 24.44
24.94
1 month 23.92
Extreme 23.925
25.35
Current year 18.99
Extreme 18.99
25.98
1 year 18.99
Extreme 18.99
25.98
3 years 14.84
Extreme 14.84
25.98
5 years 14.84
Extreme 14.84
48.89
10 years 8.31
Extreme 8.31
48.89
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%-2.13% - - 6.69B
+3.13%-0.50%-24.87%+4.45% 169B
+1.81%-1.77%-10.68%+15.46% 110B
+3.26%+3.29%-22.36%+7.39% 106B
+1.19%-1.10%-47.66%-11.35% 73.87B
+1.94%+3.52%+3.02%+69.97% 58.98B
+1.32%+4.32%+14.41%+64.37% 51.28B
+1.86%-2.06%-6.22%-31.03% 48.16B
+1.74%-0.20%-15.89%+22.64% 40.84B
+1.65%+0.21%+30.90%+3.41% 32.21B
Average +1.88%-0.86%-8.82%+16.15% 76.69B
Weighted average by Cap. +2.23%-1.30%-14.92%+13.57%

Financials

2026 *2027 *
Net sales 35.32B 3.52B 3.14B 2.92B 2.66B 5.01B 339B 5.05B 13.74B 173B 13.2B 12.92B 556B 37.44B 3.73B 3.33B 3.1B 2.82B 5.31B 359B 5.35B 14.57B 183B 14B 13.69B 589B
Net income 3.18B 316M 282M 263M 239M 451M 30.48B 454M 1.24B 15.56B 1.19B 1.16B 50B 3.58B 356M 318M 296M 270M 508M 34.33B 511M 1.39B 17.52B 1.34B 1.31B 56.32B
Net Debt 8.21B 818M 729M 679M 618M 1.16B 78.74B 1.17B 3.19B 40.19B 3.07B 3B 129B 6.04B 602M 537M 500M 455M 857M 57.95B 863M 2.35B 29.58B 2.26B 2.21B 95.07B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change Volume
05/10/26 US$24.76 +0.96% 1,081
02/10/26 US$24.52 +0.12% 797
01/10/26 US$24.49 -0.81% 4,703
30/09/26 US$24.69 +0.28% 3,823
29/09/26 US$24.62 -2.66% 2,295
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
246.40SEK
Average target price
252.20SEK
Spread / Average Target
+2.35%

Quarterly revenue - Rate of surprise